Todos Medical Ltd. (OTCQB:TOMDF) CEO Gerald Commis
Post# of 30027
Commissiong says Todos intends to use the proceeds from the Investment primarily to retire outstanding convertible notes, complete the acquisition of Provista Diagnostics for its Videssa breast cancer test and its COVID-19 PCR testing capabilities, and general working capital.
https://www.youtube.com/watch?v=koXAGE2HkKA